Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors

NCT00186225
completednot_applicable

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

NCT00186342
completednot_applicable

Allo BMT in Advanced Leukemia or High Grade Lymphoma

NCT00186290
completedphase_2

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

NCT00186394

Clinical Trials (4)

Showing 4 of 4 trials
NCT00186225Not Applicable

Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors

Completed
NCT00186342Not Applicable

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Completed
NCT00186290Not Applicable

Allo BMT in Advanced Leukemia or High Grade Lymphoma

Completed
NCT00186394Phase 2

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4